Showing results (4721-4730 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|October 17, 2022
Can MRI Be Used as a Sole Diagnostic Modality in Determining Clinical Stage in Cervical Cancer?Anke Smits, Maud Steins, Sebastiaan van Koeverden, et al.
The Oncologist|September 26, 2022
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 StudyJohn D Powderly, Samuel J Klempner, Aung Naing, et al.
The Oncologist|June 19, 2012
More than just skin deep: faciocutaneous clues to genetic syndromes with malignanciesZhu Shen, Jodi D Hoffman, Fei Hao, et al.
The Oncologist|September 8, 2012
The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective studyMarco Tampellini, Azzurra Ottone, Elisa Bellini, et al.
The Oncologist|September 11, 2012
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensusRené Adam, Aimery De Gramont, Joan Figueras, et al.
The Oncologist|September 14, 2012
Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.SDai Chihara, Hidemi Ito, Tomohiro Matsuda, et al.
The Oncologist|August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
The Oncologist|September 28, 2012
The importance of supportive care in optimizing treatment outcomes of patients with advanced prostate cancerFlorian Scotté
The Oncologist|September 18, 2012
The value of ultrasound in detecting extra-axillary regional node involvement in patients with advanced breast cancerPuneeth Iyengar, Eric A Strom, Yu-Jing Zhang, et al.
The Oncologist|August 3, 2012
Brentuximab vedotin in transplant-naive patients with relapsed or refractory hodgkin lymphoma: analysis of two phase I studiesAndres Forero-Torres, Michelle Fanale, Ranjana Advani, et al.
Pageof 571